A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

Ahead of this weekend's Super Bowl, some good news for the athletes: NFL players are largely avoiding opioid-based pain ...

The odds of a government shutdown are surging as President Trump battles Democrats over efforts to freeze funding and ...

Teen Mom' alum Kailyn Lowry says she's tapering off pain meds because she doesn't want to get addicted after her tummy tuck.

Jen Moore, 35, a former wedding cake baker, said she was unable to stand up straight when she first began experiencing painful periods as a girl of 11 years old.

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for non-opioid pain treatments that could help quell the still raging opioid ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The medication reduces pain "by targeting a pain-signaling pathway ... medication not eat or drink anything containing grapefruit. After the announcement of Journavx’s receipt of FDA approval ...